AliveCor Introduces First iOS App Combining ECG and Blood Pressure to Manage Heart Health
Partnership with Omron Healthcare will Integrate Critical Indicators in One Platform to Help Patients and Caregivers Address Heart Disease and Lower the Risk of Stroke
MOUNTAIN VIEW, Calif., Sept. 8, 2016 /PRNewswire/ – AliveCor, the leader in FDA-cleared mobile electrocardiogram (ECG) technology for mobile devices, today announced that it will integrate data from Omron Healthcare Bluetooth®-enabled home blood pressure devices into its ECG Kardia Mobile application. This new app marks the first consumer-ready, clinically validated ECG and blood pressure monitor to provide patients with a more complete view of their heart health, improve proactive monitoring and create a new standard of care for people at risk of stroke.
Heart disease is the number one cause of death in the United States, claiming more lives than all forms of cancer combined. Stroke is the third leading cause of death and the leading cause of serious, long-term disability. Hypertension among patients with Atrial Fibrillation (AF) is associated with 50 percent increased risk of stroke.*
While it is critical for patients to closely monitor AF and blood pressure to manage the risk of stroke, until now, no single platform has integrated the two risk factors. AliveCor and Omron are enabling patients to take control of their heart health with clinically validated technology and to work with their physicians to determine an appropriate care plan that will help lower the risk of stroke.
“Giving patients the ability to monitor two vital heart health statistics for stroke in one place has the opportunity to be life-changing,” said Dr. David Albert, Founder and Chief Medical Officer at AliveCor. “With this combined data, patients can change their most important modifiable risk factor, blood pressure, and seek the right care that could improve heart health and prevent a stroke. Today we are one step closer to achieving our mission of making the ECG a vital statistic for not just cardiologists, but patients, physicians and caregivers.”
“The stakes for improving heart health are at an all-time high with heart disease and stroke on the rise. Working with Omron, we are, for the first time, able to improve the detection and care path for people at risk for stroke by closely monitoring both AF and blood pressure,” said Vic Gundotra, AliveCor CEO. “Offering this consumer-ready, clinically validated platform gives a more complete view of heart health and provides a powerful way for patients to play an integral role in their own health management.”
“Our partnership with AliveCor reinforces Omron Healthcare’s commitment to innovation that provides deeper insights, encourages behavioral change and promotes healthier lifestyle habits,” said Ranndy Kellogg, president and chief executive officer of Omron Healthcare, Inc. “The combination of precise technology generating accurate readings, and the ability to track and share that data easily, results in better treatment plans and better outcomes.”
For AliveCor, this marks a big step forward in creating a new machine-learning driven system that makes it easier for physicians to determine better treatment and for patients to take a more active role in their care. AliveCor is learning more about how consumers capture heart health data as the number of ECGs recorded on the Kardia Mobile device reaches nearly 10 million. The integration with Omron’s connected blood pressure monitoring devices will further propel Kardia Mobile to becoming a leading indicator for heart conditions.
The Kardia mobile iOS app with the Omron Healthcare blood pressure integration is available to download from iTunes at https://itunes.apple.com/app/aliveecg/id579769143 and will be available soon for Android devices.
*Duke Medicine. (2014). High Blood Pressure Increases Risk of Stroke for Atrial Fibrillation Patients [Press Release]. Retrieved from http://corporate.dukemedicine.org/news_and_publications/news_office/news/high-blood-pressure-increases-risk-of-stroke-for-atrial-fibrillation-patients
About AliveCor, Inc.
AliveCor, Inc. is pioneering the creation of FDA-cleared ‘machine learning’ techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared Kardia Mobile is the most clinically validated mobile ECG solution on the market and is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. This simple to use mobile device and app-based service provides instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an ECG. AliveCor was recognized as a 2015 Tech Pioneer by the World Economic Forum and one of the 50 Smartest Companies in 2015 by the MIT Technology Review (#14). AliveCor is a privately-held company headquartered in Mountain View, Calif. For more information, please visit alivecor.com.
AliveCor is a trademark of AliveCor, Inc., registered in the U.S. and other countries.
For more information on where to buy Kardia Mobile please visit store.alivecor.com.
For more information on partnership inquiries, please contact the following:
About Omron Healthcare, Inc.
Omron Healthcare, Inc. is a leading manufacturer and distributor of personal heart health and wellness products. Omron’s market-leading products include home blood pressure monitors and electrotherapy devices. Since Omron invented its first blood pressure monitors more than 40 years ago, the company has been passionate about empowering people to take charge of their health at home through precise technology. Helping people improve their ability to live a healthier life is the heart and soul of Omron’s purpose. For more information, visit OmronHealthcare.com.
Media Contacts Lauren Kido Highwire PR for AliveCor email@example.com 415-963-4174
Susan Goodell MWWPR for Omron Healthcare firstname.lastname@example.org 312-981-8545